iX Biopharma Ltd. (SGX:42C)

iX Biopharma Revenue

In the fiscal year ending June 30, 2025, iX Biopharma had annual revenue of 7.77M SGD with 30.34% growth. iX Biopharma had revenue of 4.05M in the half year ending June 30, 2025, with 19.76% growth.

• Revenue: 7.77M
• Revenue Growth: +30.34%
• P/S Ratio: 24.71
• Revenue / Employee: 221.91K
• Employees: 35
• Market Cap: 191.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	7.77M	1.81M	30.34%
Jun 30, 2024	5.96M	46.00K	0.78%
Jun 30, 2023	5.91M	-8.48M	-58.91%
Jun 30, 2022	14.39M	12.65M	724.64%
Jun 30, 2021	1.75M	760.00K	77.16%